226 related articles for article (PubMed ID: 36451129)
1. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.
Ikuta K; Nakagawa S; Yamawaki C; Itohara K; Hira D; Imai S; Yonezawa A; Nakagawa T; Sakuragi M; Sato N; Uchino E; Yanagita M; Terada T
BMC Nephrol; 2022 Nov; 23(1):383. PubMed ID: 36451129
[TBL] [Abstract][Full Text] [Related]
2. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.
Ikuta K; Nakagawa S; Momo K; Yonezawa A; Itohara K; Sato Y; Imai S; Nakagawa T; Matsubara K
BMJ Open; 2021 Feb; 11(2):e041543. PubMed ID: 33589451
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
4. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
[TBL] [Abstract][Full Text] [Related]
5. Self-controlled Case Series Study for Acute Kidney Injury after Starting Proton Pump Inhibitors or Potassium-Competitive Acid Blocker in Patients with Cancer Using a Large Claims Database.
Suzuki K; Watanabe A; Kiryu Y; Inoue E; Momo K
Biol Pharm Bull; 2024; 47(2):518-526. PubMed ID: 38403662
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
[TBL] [Abstract][Full Text] [Related]
7. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study.
Zhang Y; Ghahramani N; Razjouyan H; Ba DM; Chinchilli VM
BMC Nephrol; 2023 May; 24(1):150. PubMed ID: 37237361
[TBL] [Abstract][Full Text] [Related]
8. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
Wu B; Li D; Xu T; Luo M; He Z; Li Y
Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
[TBL] [Abstract][Full Text] [Related]
12. Impact of combining vancomycin with proton pump inhibitors on the incidence of acute kidney injury.
Aljohani HA; Alharbi HA; Basurrah SA; Alamoudi SA; Thabit AK
Basic Clin Pharmacol Toxicol; 2022 Sep; 131(3):189-195. PubMed ID: 35665603
[TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
[TBL] [Abstract][Full Text] [Related]
14. Risk of acute kidney injury following community prescription of antibiotics: self-controlled case series.
Rennie TJW; De Souza N; Donnan PT; Marwick CA; Davey P; Dreischulte T; Bell S
Nephrol Dial Transplant; 2019 Nov; 34(11):1910-1916. PubMed ID: 29961876
[TBL] [Abstract][Full Text] [Related]
15. Association of Proton Pump Inhibitor Use With Risk of Acquiring Drug-Resistant Enterobacterales.
Willems RPJ; Schut MC; Kaiser AM; Groot TH; Abu-Hanna A; Twisk JWR; van Dijk K; Vandenbroucke-Grauls CMJE
JAMA Netw Open; 2023 Feb; 6(2):e230470. PubMed ID: 36821114
[TBL] [Abstract][Full Text] [Related]
16. Association Between Proton Pump Inhibitor Exposure and Acute Kidney Injury After Cardiac Surgery.
Koh HB; Joo YS; Kim HW; Jo W; Chan Kang S; Jhee JH; Han M; Lee M; Han SH; Yoo TH; Kang SW; Park JT
Mayo Clin Proc; 2023 Feb; 98(2):266-277. PubMed ID: 36737115
[TBL] [Abstract][Full Text] [Related]
17. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Varma S; Trudeau SJ; Li J; Freedberg DE
Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215
[TBL] [Abstract][Full Text] [Related]
18. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.
Lee J; Mark RG; Celi LA; Danziger J
J Clin Pharmacol; 2016 Dec; 56(12):1500-1506. PubMed ID: 27492273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]